Table 5

Response by FcγR polymorphisms (best overall response)

FcγR IIaFcγR IIIa
HR (n = 7)HH (n, 5)RR (n = 5)FF (n = 10)VV (n = 3)FV (n = 4)
Responder, n (%)2 (29)3 (60)3 (60)5 (50)2 (67)1 (25)
Nonresponder, n (%)5 (71)2 (40)2 (40)5 (50)1 (33)3 (75)
  • Response was defined as CR/CRu or PR; nonresponse was defined as progressive disease or SD. FcγR polymorphism data were available for 20 patients.